ArticleBlood2023
Monoclonal gammopathy of thrombotic/thrombocytopenic significance.
Abstract read
In one paragraph
Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significance.Haematologica · 2026Review
- Monoclonal Gammopathy of Thrombotic Significance.American journal of hematology · 2026Review
- Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT.American journal of hematology · 2026Article
- Etiology and management of venous thromboembolism recurrence in patients anticoagulated for venous thromboembolism: a single-center study.Research and practice in thrombosis and haemostasis · 2026Article
- Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia.Journal of thrombosis and haemostasis : JTH · 2026Article
- Anti-Platelet Factor 4 Antibody Clonal Heterogeneity and MGUS Status in HIT.medRxiv : the preprint server for health sciences · 2026Article
- Monoclonal gammopathy of clinical significance: a multisystem review.Blood cancer journal · 2026Review
- Monoclonal gammopathy of thrombotic significance in a nutshell.British journal of haematology · 2026Review
- Monoclonal Gammopathy of Neurological Significance: Toward an Integrated Hematologic-Neurologic Perspective-A Single-Center Retrospective Study.International journal of molecular sciences · 2026Article
- Classification of Platelet-Activating Anti-Platelet Factor 4 Disorders.International journal of laboratory hematology · 2026Review
- Microfluidic Electrochemical Biosensor for the Detection of Platelet Factor 4 Antibody-Mediated Thrombotic Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)-like Syndrome: A Case Report and Some Considerations on a Novel Diagnostic and Therapeutic Challenge.Diagnostics (Basel, Switzerland) · 2026Article
- Third-Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance (MGTS).American journal of hematology · 2025Article
- Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia.medRxiv : the preprint server for health sciences · 2025Article
- Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT.medRxiv : the preprint server for health sciences · 2025Article
- M protein and the evolving spectrum of platelet-activating anti-PF4 disorders and MGTS and their linkage.Blood vessels, thrombosis & hemostasis · 2025Article
- Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia.The New England journal of medicine · 2025Article
- Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss.The New England journal of medicine · 2025Article
- VITT Pathophysiology: An Update.Vaccines · 2025Review
- Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.British journal of haematology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Adam J KanackDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Jordan K SchaeferDepartment of Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-7166-386X
Meera SridharanDepartment of Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-7225-8228
Noah P SplinterDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Mindy C KohlhagenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Bandana SinghDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Silvana B De LorenzoDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Emily E MauchDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Maen A HusseinFlorida Cancer Specialists, Orlando, FL.
Marwan ShaikhDepartment of Medicine, Mayo Clinic, Jacksonville, FL.
Shaji KumarDepartment of Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5392-9284
Renren WenDepartment of Microbiology and Immunology, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0003-2420-8212
Demin WangDepartment of Microbiology and Immunology, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0001-5549-3795
David MurrayDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Anand PadmanabhanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.ORCID 0000-0003-2519-4377
Funding
B cell responses in heparin-induced thrombocytopeniaR01HL130724 · NHLBI · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2017 to 2024
$4.8MMolecular Basis of the Humoral Immune Response in Heparin-Induced ThrombocytopeniaR01HL148120 · NHLBI · VERSITI WISCONSIN, INC. · PI Renren Wen · 2019 to 2026
$3.8MB-cell response and thrombotic complications in COVID-19R01HL161127 · NHLBI · VERSITI WISCONSIN, INC. · PI WEN, RENREN · 2022 to 2025
$2.6MNew approaches to the pathophysiology, diagnosis and management of heparin-induced thrombocytopeniaR01HL158932 · NHLBI · MAYO CLINIC ROCHESTER · PI PADMANABHAN, ANAND · 2021 to 2025
$2.0MNHLBI NIH HHS R01 HL130724NHLBI NIH HHS R01 HL148120NHLBI NIH HHS R01 HL158932NHLBI NIH HHS R01 HL161127
Abstract
PubMed holds no abstract for this paper.
Indexed as
Monoclonal Gammopathy of Undetermined SignificanceParaproteinemiasThrombosisHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.